BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register

LBRX

LB Pharmaceuticals Inc Common Stock NASDAQ Listed Sep 11, 2025
$37.80
-3.55% vs $39.19
Mkt Cap $956.3M
52w Low $14.61 66.5% of range 52w High $49.48
50d MA $43.28 200d MA $30.40
P/E (TTM) -12.7x
EV/EBITDA —
P/B 3.2x
Debt/Equity 0.0x
ROE -8.4%
P/FCF -27.1x
RSI (14) 18.80
ATR (14) $2.15
Beta -0.18
50d MA $43.28
200d MA $30.40
Avg Volume 295.9K
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.
CIK (SEC)
Phone
212 605 0300
One Pennsylvania Plaza · New York, NY 10119 · US
Data updated apr 25, 2026 6:36pm · Source: financialmodelingprep.com